SCHEMBL24313765

SCHEMBL24313765

CCOc1ccc(C(C)CC)cc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 3/20 0.38
TSHR P16473 3/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
ALOX12 P18054 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALPL P05186 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469835 1.00 ALDH1A1 (0.41) ALDH1A1USP2GAAPKMHPGD
SCHEMBL19122117 0.86 ALDH1A1 (0.45) ALDH1A1GAALMNATSHRMAPT
SCHEMBL24313766 0.81 TAS1R3 (0.47) ALDH1A1USP2GAAPKMHPGD
SCHEMBL23130388 0.81 MAPT (0.54) ALDH1A1GAALMNATSHRTP53
SCHEMBL20459373 0.81 ALDH1A1 (0.51) ALDH1A1GAALMNATP53MAPT
SCHEMBL18713469 0.79 MAPT (0.45) ALDH1A1USP2GAAPKMHPGD
SCHEMBL18713700 0.79 KDM1A (0.45) ALDH1A1USP2GAAPKMHPGD
SCHEMBL19965694 0.77 LMNA (0.47) ALDH1A1USP2GAAPKMHPGD
SCHEMBL10138860 0.77 GAA (0.59) ALDH1A1USP2GAAPKMHPGD
SCHEMBL18713475 0.77 HTT (0.49) ALDH1A1USP2GAAPKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed